These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Rational design of Salmonella recombinant vaccines. Cheminay C, Hensel M. Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730 [Abstract] [Full Text] [Related]
8. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet? Lewis GK. Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757 [Abstract] [Full Text] [Related]
10. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery. Phalipon A, Sansonetti P. Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655 [Abstract] [Full Text] [Related]
14. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria. Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, Chakravortty D. Vaccine; 2009 May 11; 27(21):2804-11. PubMed ID: 19428891 [Abstract] [Full Text] [Related]
15. Bivalent vaccines against bacterial enteropathogens: construction of live attenuated vaccine strains with two O-serotype specificities. Viret JF, Favre D. Biologicals; 1994 Dec 11; 22(4):361-72. PubMed ID: 7540016 [Abstract] [Full Text] [Related]